The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Corcept Therapeutics Inc shares valued at $141,524 were sold by Lyon Joseph Douglas on Apr 04 ’24. At $26.00 per share, Lyon Joseph Douglas sold 5,443 shares. The insider’s holdings dropped to 7,314 shares worth approximately $0.17 million following the completion of this transaction.
Also, Swisher Daniel N JR sold 2,200 shares, netting a total of over 55,660 in proceeds. Following the sale of shares at $25.30 each, the insider now holds 0 shares.
Before that, Lyon Joseph Douglas had sold 500 shares from its account. In a trade valued at $13,004, the insider traded Corcept Therapeutics Inc shares for $26.01 each. Upon closing the transaction, the insider’s holdings decreased to 500 shares, worth approximately $0.17 million.
As published in a research note from Truist on November 06, 2023, Corcept Therapeutics Inc [CORT] has been rated up from a Hold to a Buy and the price target has been revised to $38 from $29. Analysts at SVB Securities started covering the stock with ‘”a Market perform”‘ outlook in a report released in mid April. As of April 04, 2023, Piper Sandler has initiated its “an Overweight” rating for CORT. Earlier on February 15, 2023, Jefferies downgraded its rating. Their new recommendation was “a Hold” for CORT stock which previously was a “a Buy”.
Analyzing CORT Stock Performance
During the last five days, there has been a drop of approximately -4.91%. Over the course of the year, Corcept Therapeutics Inc shares have dropped approximately -26.66%. Shares of the company reached a 52-week high of $27.54 on 01/08/24 and a 52-week low of $20.87 on 02/02/24. A 50-day SMA is recorded $23.71, while a 200-day SMA reached $26.53. Nevertheless, trading volume fell to 0.57 million shares from 0.86 million shares the previous day.
Support And Resistance Levels for Corcept Therapeutics Inc (CORT)
According to the 24-hour chart, there is a support level at 23.44, which, if violated, would cause prices to drop to 23.06. In the upper region, resistance lies at 24.15. The next price resistance is at 24.48. RSI (Relative Strength Index) is 45.43 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.55, which suggests the price will decrease in the coming days. Percent R is at 78.35%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Corcept Therapeutics Inc subject to short interest?
Stocks of Corcept Therapeutics Inc saw a sharp rise in short interest on Mar 15, 2024 jumping by 0.58 million shares to 20.22 million. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 19.64 million shares. A jump of 2.87% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 18.88 of the overall float, the days-to-cover ratio (short ratio) jumped to 18.88.
